SCHEMBL23054728

SCHEMBL23054728

C#C[C@]1(CO)O[C@@](C#N)(c2ccc3c(N)nc(N)nn23)C(O)C1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23054726 0.91 — —
SCHEMBL23054722 0.84 TMPRSS2 (0.38) —
SCHEMBL23054724 0.84 — —
SCHEMBL23054727 0.79 — —
SCHEMBL22372336 0.79 TMPRSS2 (0.40) —
SCHEMBL20834797 0.79 TMPRSS2 (0.40) —
SCHEMBL23054753 0.72 BTN3A1 (0.41) —
SCHEMBL23054692 0.72 POLRMT (0.32) —
SCHEMBL29323884 0.72 POLRMT (0.32) —
SCHEMBL29323088 0.72 POLRMT (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210060051-A1 COMBINED MODALITIES FOR NUCLEOSIDES AND/OR NADPH OXIDASE (NOX) INHIBITORS AS MYELOID-SPECIFIC ANTIVIRAL AGENTS EMORY UNIVERSITY 2021-03-04 — — US disclosed
Send feedback